MCUJF (Medicure) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MCUJF Medicure Inc MCUJF
63 GF Score
Price $0.81
GF Value $1.12
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Medicure FFO?

FFO (Funds from operations) only applies to REITs.

MCUJF
63GF Score
Medicure Inc MCUJF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medicure (MCUJF) Overvalued in 2026?

Based on GuruFocus' analysis, Medicure stock appears to be undervalued. The current stock price of $0.81 is trading 27.8% below its estimated GF Value™ of $1.12. GuruFocus considers Medicure to be Modestly Undervalued.

Key valuation signals for MCUJF:

  • FFO:
  • GF Value™: $1.12 vs. price of $0.81 (27.8% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the MCUJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicure Business Description

Other Exchanges MPH:Canada
Address 1250 Waverley Street, No. 2, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
63GF Score

Get the complete analysis for MCUJF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.81
Price
$1.12
GF Value